U.S Emerging Prostate Cancer Therapeutics Market

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This report on the U.S. Emerging Prostate Cancer Therapeutics Market gives detailed information about revenue forecasts, market shares, projected prevalence of disease and therapeutic options according to disease stage, namely localized, locally advanced, and metastatic prostate cancer. Key market and technology trends are discussed relative to the future of the market. The report also covers market drivers and restraints, major challenges facing the industry and offers strategies to address these challenges.

Table of Contents

U.S Emerging Prostate Cancer Therapeutics Market, Executive SummaryMarket OverviewIntroductionU.S Emerging Prostate Cancer Therapeutics Market, IntroductionOverviewScope and SegmentationEpidemiology and EtiologyStaging of Prostate CancerMarket TrendsTechnology Trends- Gene TherapyTechnology Trends- OthersMarket DynamicsTop Three ChallengesChallenges - OthersTop Three DriversDrivers - OthersTop Three RestraintsRestraints - OthersStrategic RecommendationsStrategies OverviewStrategic Recommendations for Market Challenge 1Strategic Recommendations for Market Challenge 2Strategic Recommendations for Market Challenge 3Strategic Recommendations for Market Challenge 4Strategic Recommendations for Market Challenge 5Strategic Recommendations for Market Challenge 6Frost & Sullivan Market Engineering AwardsTechnology Innovation Award : Dendreon CorporationStrategic Alliance Leadership : Praecis PharmaceuticalsTechnology Leadership : Medarex Inc.Website Leadership : Ilex OncologyEntrepreneurial Company : Cytran U.S Emerging Prostate Cancer Therapeutics Market, Localized Prostate Cancer Therapeutics MarketOverviewIntroductionExisting TherapiesOther TherapiesMarket Engineering AnalysisForecasts and TrendsDemand AnalysisRevenue ForecastsPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis-Existing ProductsProduct Analysis-Emerging Products : Hormones and ChemotherapeuticsProduct Analysis-Emerging Products : ImmunotherapeuticsU.S Emerging Prostate Cancer Therapeutics Market, Locally Advanced Prostate Cancer Therapeutics MarketOverviewIntroductionExisting TherapiesInvestigational TherapiesMarket Engineering AnalysisForecasts and TrendsDemand AnalysisRevenue Forecast Model and AssumptionsRevenue ForecastsCurrent Pricing TrendsFuture Pricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis-Existing ProductsProduct Analysis-Emerging Products : HormonesProduct Analysis-Emerging Products : Chemotherapeutics and OthersProduct Analysis-Emerging Products : ImmunotherapeuticsU.S Emerging Prostate Cancer Therapeutics Market, Metastatic Prostate Cancer Therapeutics MarketOverviewIntroductionExisting Therapies - Hormones and Other AAI'sExisting Therapies - ChemotherapyFuture TherapiesMarket Engineering AnalysisForecasts and TrendsDemand AnalysisRevenue Forecast Model and AssumptionsRevenue ForecastCurrent Pricing TrendsFuture Pricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis-Existing ProductsProduct Analysis-Emerging Products : HormonesProduct Analysis-Emerging Products : Chemotherapeutics and OthersProducts Analysis-Emerging Products : ImmunotherapeuticsProduct Analysis-Other Emerging Products




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.